Optical Genome Mapping Reveals Novel Structural Variants in Lymphoblastic Lymphoma

• Published in: Journal of pediatric hematology/oncology Vol. 46; no. 1; p. e71
• Main Authors: Xu, Hanli, Gao, Huixia, Wang, Chanjuan, Cheng, Xiyu, Li, Zhigang, Lei, Cui, Huang, XiaoTong, Li, Weijing, Yue, Zhixia, Tian, Shuo, Zhao, Xiaoxi, Xue, Tianlin, Xing, Tianyu, Li, Jun, Wang, Ying, Duan, Yanlong, Wang, Tianyou, Zhang, Ruidong
• Format: Journal Article
• Language: English
• Published: United States 01.01.2024
• Subjects: Child; Chromosome Mapping; DNA Copy Number Variations; Exons; Humans; Lymphoma, Non-Hodgkin; Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics
• ISSN: 1536-3678
• DOI: 10.1097/MPH.0000000000002787

Accurate histologic and molecular genetic diagnosis is critical for the pathogenesis study of pediatric patients with lymphoblastic lymphoma (LBL). Optical genome mapping (OGM) as all-in-one process allows the detection of most major genomic risk markers, which addresses some of the limitations associated with conventional cytogenomic testing, such as low resolution and throughput, difficulty in ascertaining genomic localization, and orientation of segments in duplication, inversions, and insertions. Here, for the first time, we examined the cytogenetics of 5 children with LBL using OGM. OGM was used to analyze 5 samples of pediatric LBL patients treated according to the modified NHL-BFM95 backbone regimen. Whole-exon Sequencing (WES) was used to confirm the existence of structural variants (SVs) identified by OGM with potentially clinical significance on MGI Tech (DNBSEQ-T7) platform. According to the fusion exon sequences revealed by WES, the HBS1L :: AHI1 fusion mRNA in case 4 was amplified by cDNA-based PCR. In total, OGM identified 251 rare variants (67 insertions, 129 deletions, 3 inversion, 25 duplications, 15 intrachromosomal translocations, and 12 interchromosomal translocations) and 229 copy number variants calls (203 gains and 26 losses). Besides all of the reproducible and pathologically significant genomic SVs detected by conventional cytogenetic techniques, OGM identified more SVs with definite or potential pathologic significance that were not detected by traditional methods, including 2 new fusion genes, HBS1L :: AHI1 and GRIK1::NSDHL , which were confirmed by WES and/or Reverse Transcription-Polymerase Chain Reaction. Our results demonstrate the feasibility of OGM to detect genomic aberrations, which may play an important role in the occurrence and development of lymphomagenesis as an important driving factor.